We have reported recently the first birth after intrauterine transfer of embryos obtained by injection of round spermatids into oocytes in cases of unexpected azoospermia. Here we provide a complete documentation of the series of 11 cases hi which this novel method of infertility treatment was employed. In four of these cases, elongated spermatids were identified in the ejaculate, and it was decided to perform elongated spermatid injection (ELSI). In the other six cases, only round spermatids were present, and round spermatid injection (ROSI) was done. In one case, ROSI was given preference to ELSI because of a very poor viability status of elongated spermatids present in the ejaculate. Fertilization of at least one oocyte was achieved hi 10 of the 11 treatment cycles,* the fertilization rate in these 10 cycles ranged between 7 and 100% with a mean value of 45%. All of the two-pronucleated zygotes cleaved and were transferred to the patient's uterus. A singleton pregnancy was achieved hi two ROSI cycles. Both pregnancies developed uneventfully and resulted in the birth of normal infants. These data show that intra-ooplasmic injection of spermatids obtained from the ejaculate may become the treatment of first choice hi patients with nonobstructive azoospermia.
Introduction
Only a little more than a decade ago, patients with azoospermia were considered irreversibly excluded from the reproduction process. The first reported pregnancy resulting from conventional in-vitro fertilization (TVF) using spermatozoa aspirated from the epididymis (Temple-Smith et al., 1985) suggested a new approach to the treatment of certain forms of azoospennia, but the chance of success remained low because sufficient numbers of good-quality spermatozoa could not be obtained in most cases. The recent improvements of the techniques of micromanipulation-assisted fertilization has dramatically changed this situation in those patients in whom azoospermia is caused by blockage of sperm output due either to primary agenesis or to secondary obstruction of efferent ducts while spermatozoa continue to be produced in the testis. In fact, results obtained by intracytoplasmic sperm injection (ICSI) using spermatozoa retrieved by microsurgical (Silber, 1994) or percutaneous (Craft et al, 1995) epididymal sperm aspiration, or by testicular biopsy (Craft et al, 1993; Silber et al, 1995) have been very encouraging. However, spermatozoa cannot be obtained by any of these methods in many cases of azoospermia due to defective testicular spermatogenetic function which may be caused by different etiological factors. Previous reports on successful fertilization of human oocytes by spermatids and on implantation of such embryos after uterine transfer (Fishel et al, 1995) suggested that viable human embryos can be obtained by injection of spermatids into oocytes and thus opened a new perspective to the treatment of non-obstructive azoospermia. The feasibility of this novel approach has been confirmed by the first birth of a healthy child after round spermatid injection into human oocytes .
The usefulness and range of application of spennatid injection will obviously depend on the presence and viability status of spermatids that can be recovered from the ejaculates of patients suffering from non-obstructive azoospermia as well as on the performance of this novel method of assisted conception in terms of fertilization, cleavage and pregnancy rates (Edwards et al, 1994) . hi this study, we report complete information about these issues from a series of 11 cases of non-obstructive azoospennia in which spermatid injection has been performed.
Materials and methods
This study deals with 11 infertile couples attending our ICSI programme. The mean age of the husband was 36 years (range, 30-48 years) , that of the wife was 32 years (range 27-43 years). No apparent reproductive pathology was detected in the females during previous examinations. Both partners of each of these couples were examined for karyotype and the presence of HTV antibodies. All of these examinations gave normal results. Previous spermiograms available for the husbands, the last of which was performed no longer than 1 month before the planned ICSI procedure, showed a severe oligozoospermia with only a few spermatozoa detected in the sediment after whole ejaculate centrifugarion but not a complete absence of spermatozoa. Accordingly, an ICSI was judged feasible. Unexpectedly, no spermatozoa were found in the ejaculates of these men on the day of ICSI; this occurred in 2% of the total number of ICSI treatment cycles. After having obtained informed consent from the couples, we thus decided to try to fertilize oocytes by injecting spermatids rather than spermatozoa.
The methods for spermatid preparation and viability assessment have been described elsewhere (Tesarik and Mendoza, 1996) . In view of the limited availability of spermatids in these preparations, the viability assessment was based on examination of only 20 cells for both round and elongated spermatids. TTie methods for oocyte recovery and preparation were the same as in our standard ICSI programme (Tesarik and Mendoza, 1996) .
The presence and viability status of different types of spermatids in individual azoospennic ejaculates were the main criteria used to determine whether round spermatid injection (ROSI) or elongated spermatid injection (ELSI) was to be performed in each given treatment cycle. Finer distinction of substages of round and elongated spermatid development (Clermont, 1963) was not done because of the limited possibilities of distinguishing cytological details in native unstained cells. The technique of spermatid injection has been described in detail elsewhere (Tesarik and Mendoza, 1996) . After injection, oocytes were cultured at 37°C in IVF medium (Medi-Cult) equilibrated with 5% CO 2 in air.
Fertilization was assessed by three consecutive inspections of the oocytes performed at 10-12 h, at 16-18 h, and at 22-24 h after injection. Zygotes are referred to as two-pronucleated when two pronuclei were clearly visible on at least one of these three occasions. The occurrence of three-pronucleated zygotes and parthenogenetically activated, one-pronucleated oocytes was also determined Care was taken to distinguish between diploid zygotes at the syngamy stage and one-pronucleated haploid oocytes (Tesarik and Mendoza, 1996) . Zygotes were cultured further at 37°C in IVF medium (Medi-Cult) equilibrated with 5% CO2 in air until 2 days after spermatid injection. Embryos that had undergone at least one cleavage division by that time were transferred to the patient's uterus. One to four embryos were transferred at once in individual patients. Surplus embryos were frozen. During the whole culture period from spermatid injection to embryo transfer, the medium was changed once, during the second examination for the signs of fertilization performed at 16-18 h after injection.
Results

Occurrence and viability status of round and elongated spermatids in azoospennic ejaculates
Data concerning the presence and viability of round and elongated spermatids in the ejaculates of the 11 patients included in this study are summarized in Table I where patients are numbered in a chronological order with respect to the date of the ROSI or ELSI procedure. In all cases, round spermatids were found, and most of them were viable according to this study criteria. Elongated spermatids were present in five out of the 11 cases only. Their viability was highly variable and always appeared lower than that of round spermatids found in the same ejaculate (Table I) . In six cases, no elongated spermatids were identified. No attempt was made to differentiate between individual developmental stages of round and elongated spermatids.
Fertilization and preimplantation embryonic development after spermatid injection into oocytes
Fertilization outcomes obtained in the 11 treatment cycles in which oocytes were injected with round or elongated spermatids are shown in Table H The numbering of patients in "Viability of round spermatids was assessed by examining the behaviour of the cells during aspiration into the microinjection needle and subsequent expulsion into the 10% polyvinylpyrrohdone solution (see Tesarik and Mendoza, 1996) . Twenty cells were examined for each patient. Viability scoring: + + + +, 16-20 cells alive; + + + , 11-15 cells alive; ++, 6-10 cells alive; +, 1-5 cells alive; -, no living cell present •Viability of elongated spermatids was assessed by eosin-nigrosin staining (see Tesarik and Mendoza, 1996) . The number of cells examined and the viability scoring is the same as for round spermatids (see footnote a).
Table II corresponds to that in Table I . In 10 treatment cycles, two pronuclei developed in at least one of the injected oocytes giving a total of 28 two-pronucleated zygotes out of the 62 oocytes injected. Hence, the overall rate of normal fertilization (two pronuclei) was 45%, ranging between 0 and 100% in individual patients. Only one pronucleus was seen in seven injected oocytes indicating parthenogenetic activation. In two zygotes, three pronuclei were detected. The parthenogenetically activated oocytes and the three-pronucleated zygotes did not cleave. Three oocytes died soon after injection. The remaining oocytes neither fertilized nor underwent parthenogenetic activation and remained arrested at metaphase of the second meiotic division. All of the two-pronucleated zygotes underwent cleavage and developed into normal-appearing two-cell to fivecell embryos (Table IT) .
Embryo transfer outcomes
Details of the numbers and developmental stages of embryos transferred in each of the 10 cycles in which cleaved embryos were obtained are also shown in Table II . All embryos available were transferred in the fresh state, with the exception of one treatment cycle (patient no. 9) in which three of the six embryos developing after ELSI were frozen to be transferred in a subsequent cycle. Fortuitously, pregnancy was achieved already in the first treatment cycle in which this unorthodox method of conception was attempted; four good-quality embryos were transferred in this cycle (Table II) . Another pregnancy resulted from the fifth attempt in which four embryos were also transferred; three of these embryos were judged of good quality (Table H) . Both of these pregnancies were obtained after injection of round spermatids and continued uneventfully. The overall per embryo implantation rate was 8%. The examinations of karyotype and fetal morphology did not reveal any abnormalities in any of these two cases. The first pregnancy resulted in birth of a J.Tesarik healthy boy (3500 g birthweight). The infant was delivered by Caesarean section at 39 weeks' gestation. The other infant was also a normal boy (3700 g birthweight) and was delivered normally at 38 weeks' gestation.
Discussion
Non-obstructive azoospermia caused by defective spermatogenesis includes cases such as Kallman's syndrome, Sertoli cell only syndrome, spermatogenic arrest, post-cryptorchidism tubular atrophy, mumps or Klinefelter syndrome. In many cases, the aetiological factor responsible for this condition is not known. With the exception of Kallman's syndrome, these cases are refractory to any of the conventional modes of spermatogenesis stimulation therapy. Even though sporadic cases of non-obstructive azoospermia were reported in which a focus of weak persisting spermatogenesis could be fortuitously punctured at testicular biopsy yielding a few spermatozoa for ICSI (Devroey etal, 1995; Yemini etal., 1995) , the localization of such foci in the testis is unforeseeable. Thus, search for spermatozoa in testicular biopsy specimens from patients with non-obstructive azoospermia bears a risk of destruction of considerable volumes of testicular tissue with uncertain clinical result.
This study has suggested that the presence of round spermatids in the ejaculate is a frequent finding in patients with nonobstructive azoospermia. The present observation that a few spermatozoa can occasionally be found in the ejaculate of individuals whose ejaculates are totally devoid of spermatozoa on other occasions is in agreement with the finding of residual focal spermatogenesis in cases of non-obstructive azoospermia (Devroey et aL, 1995; Yemini et aL, 1995) . One can imagine that this limiting spermatogenesis is sufficient to allow some spermatozoa to get out of the testis and reach the ejaculate only occasionally. This was apparently the case for the patients involved in this study in whom a previous spenniogram revealed the presence of a few spermatozoa in the sediment after total ejaculate centrifugation, but no spermatozoa could be found on the day for which ICSI was planned
The presence of spermatids in the azoospermic ejaculates involved in this study may also be a result of focal testicular spermatogenic activity. Interestingly, most of the round spermatids identified in these ejaculates appeared to be living, whereas the viability scores determined for elongated spermatids in those ejaculates in which these cells were present were always lower. It is thus possible that the same pathogenetic process which leads to the disappearance of spermatogenesis in most of the testicular tubules also affects negatively the quality of sperm maturation in the persisting active spermatogenic foci so that the viability of sperm precursor cells decreases as they approach their terminal differentiation.
The fertilization rates after spermatid injection into oocytes were lower as compared with our actual ICSI results with mature spermatozoa (Tesarik and Sousa, 1995) . At first sight, the fertilization rate for ROSI appears lower than that for ELSI. However, this is only a small-series effect because this tendency disappears as the number of cases increases (Tesarik and Mendoza, 1996) . In spite of the relatively low fertilization rates after ROSI and ELSI, embryos for transfer were available in all instances with the exception of one case in which only one oocyte was retrieved and failed to be fertilized after ROSI. Until further improvements of the ROSI and ELSI techniques make it possible to approach the fertilization rates of ICSI, the use of spermatid injection does not appear suitable in cases in which only limited numbers of oocytes are available. It is also to be noted that four embryos were transferred in both cases in which a singleton pregnancy was established, and the implantation rate in the whole group of patients was relatively low. This may suggest a reduced embryonic viability associated with the use of spermatids for conception, but the number of cases appears too small to make such a straightforward conclusion. Interestingly, relatively low implantation rates have also been reported for embryos obtained with the use of spermatids or spermatid nuclei in early animal studies (Ogura et aL, 1994; Sofikitis et aL, 1994) and in an early series of human treatment cycles (Sofikitis et aL, 1995) although a substantial improvement has recently been reported in the mouse (Kimura and Yanagimachi, 1995) .
In spite of the small size of the patient group involved in this study, the present results suggest that spermatid injection into oocytes may become a treatment of the first choice for many cases of non-obstructive azoospermia. As compared to testicular biopsy coupled with ICSI, spermatid injection offers several advantages. Spermatids can be recovered from the ejaculate of azoospermic men. Thus, our method represents the least invasive approach, sparing the residual active foci of spermatogenesis eventually present in the testis. If the first attempt of spermatid injection does not lead to a pregnancy, these foci still remain intact and can thus continue to produce spermatids for subsequent attempts. This is not the case of testicular biopsy whereby the foci from which sperm cells are recovered are likely to be lost for future attempts. If spermatid injection does not definitively lead to pregnancy, testicular biopsy with ICSI can still be envisaged as the treatment of last chance. Inversely, destruction of residual spermatogenesis by excessive removal of tissue during testicular biopsy is likely to reduce the production of spermatids and thus compromises the chance of success of eventual subsequent spermatid injection treatment cycles. In view of the present results, a search for spermatids in the ejaculate should complement spermatologic examination in all patients with non-obstructive azoospermia, to decide whether spermatid injection into oocytes is feasible.
